Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Stem Cells – From Hype to Real Hope

Ed. by Haider, Khawaja Husnain / Aziz, MD, Salim

eBook (PDF)
Publication Date:
December 2018
Copyright year:
See all formats and pricing

2. Preclinical large-animal models of cardiovascular regeneration

Navarengom, Keron / Ferrante, Elisa A. / Rasmussen, Todd E. / Boehm, Manfred


The Centers for Disease Control estimates that about 5.7 million adults in the United States have heart failure (HF) and more than 550,000 new cases are diagnosed every year. The definitive treatment of end-stage HF remains orthotopic heart transplantation (OHT). The mortality rate while waiting for OHT is high (35% in 4 months) due to shortage of donor hearts. Prolonged wait periods also impose significant constraints on the health care system and patient quality of life. Despite recent advances in medical and device therapies, there are no effective long-term treatment strategies for heart attacks. To develop novel therapeutic approaches to improve blood flow to the heart, the scientific community has increasingly relied on preclinical large-animal models to test the feasibility of innovative treatments for cardiovascular regeneration. In this chapter, we provide an overview of the largeanimal models available and the therapies being investigated and review the results obtained that pave the way for breakthrough treatment strategies, with a discussion on the hurdles that must be overcome for implementation in clinical trials.

Citation Information

Keron Navarengom, Elisa A. Ferrante, Todd E. Rasmussen, Manfred Boehm (2018). 2. Preclinical large-animal models of cardiovascular regeneration. In , (Eds.), Stem Cells – From Hype to Real Hope (pp. 20–33). Berlin, Boston: De Gruyter. https://doi.org/10.1515/9783110587043-002

Book DOI: https://doi.org/10.1515/9783110587043

Online ISBN: 9783110587043

© 2018 Walter de Gruyter GmbH, Berlin/Munich/BostonGet Permission

Comments (0)

Please log in or register to comment.
Log in